A citation-based method for searching scientific literature

V Tiedje, S Ting, H Dralle, K W Schmid, D Führer. Internist (Berl) 2015
Times Cited: 5







List of co-cited articles
46 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.
Samuel A Wells, Sylvia L Asa, Henning Dralle, Rossella Elisei, Douglas B Evans, Robert F Gagel, Nancy Lee, Andreas Machens, Jeffrey F Moley, Furio Pacini,[...]. Thyroid 2015
80

2012 European thyroid association guidelines for genetic testing and its clinical consequences in medullary thyroid cancer.
R Elisei, M Alevizaki, B Conte-Devolx, K Frank-Raue, V Leite, G R Williams. Eur Thyroid J 2013
59
60

The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis.
C Eng, D Clayton, I Schuffenecker, G Lenoir, G Cote, R F Gagel, H K van Amstel, C J Lips, I Nishisho, S I Takai,[...]. JAMA 1996
779
40

RET proto-oncogene in Sardinia: V804M is the most frequent mutation and may be associated with FMTC/MEN-2A phenotype.
Giovanni Pinna, Giuseppina Orgiana, Alessia Riola, Mariangela Ghiani, Maria Letizia Lai, Carlo Carcassi, Stefano Mariotti. Thyroid 2007
37
40

Medullary thyroid cancer: management guidelines of the American Thyroid Association.
Richard T Kloos, Charis Eng, Douglas B Evans, Gary L Francis, Robert F Gagel, Hossein Gharib, Jeffrey F Moley, Furio Pacini, Matthew D Ringel, Martin Schlumberger,[...]. Thyroid 2009
826
40

BRAF inhibitor dabrafenib in patients with metastatic BRAF-mutant thyroid cancer.
Gerald S Falchook, Michael Millward, David Hong, Aung Naing, Sarina Piha-Paul, Steven G Waguespack, Maria E Cabanillas, Steven I Sherman, Bo Ma, Martin Curtis,[...]. Thyroid 2015
131
40


Clonal origin of toxic thyroid nodules with constitutively activating thyrotropin receptor mutations.
K Krohn, D Führer, H P Holzapfel, R Paschke. J Clin Endocrinol Metab 1998
64
40

Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha protein gene in 31 toxic thyroid nodules.
D Führer, H P Holzapfel, P Wonerow, W A Scherbaum, R Paschke. J Clin Endocrinol Metab 1997
111
40

Remarkable Response to Crizotinib in Woman With Anaplastic Lymphoma Kinase-Rearranged Anaplastic Thyroid Carcinoma.
Yann Godbert, Bénédicte Henriques de Figueiredo, Françoise Bonichon, Frédéric Chibon, Isabelle Hostein, Gaëlle Pérot, Camille Dupin, Agnès Daubech, Genevieve Belleannée, Audrey Gros,[...]. J Clin Oncol 2015
77
40

TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.
Miguel Melo, Adriana Gaspar da Rocha, João Vinagre, Rui Batista, Joana Peixoto, Catarina Tavares, Ricardo Celestino, Ana Almeida, Catarina Salgado, Catarina Eloy,[...]. J Clin Endocrinol Metab 2014
346
40

The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.
T Liu, N Wang, J Cao, A Sofiadis, A Dinets, J Zedenius, C Larsson, D Xu. Oncogene 2014
175
40

[Benign thyroid nodule or thyroid cancer?].
D Führer, K W Schmid. Internist (Berl) 2010
12
40

Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas.
Linda Cheung, Marinella Messina, Anthony Gill, Adele Clarkson, Diana Learoyd, Leigh Delbridge, John Wentworth, Jeanette Philips, Roderick Clifton-Bligh, Bruce G Robinson. J Clin Endocrinol Metab 2003
151
40

Comparative analysis of the thyrocytes and T cells: responses to H2O2 and radiation reveals an H2O2-induced antioxidant transcriptional program in thyrocytes.
Soetkin Versteyhe, Natacha Driessens, Chiraz Ghaddhab, Maxime Tarabichi, Candice Hoste, Jacques-Emile Dumont, Françoise Miot, Bernard Corvilain, Vincent Detours. J Clin Endocrinol Metab 2013
17
40

BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.
Mingzhao Xing, Rengyun Liu, Xiaoli Liu, Avaniyapuram Kannan Murugan, Guangwu Zhu, Martha A Zeiger, Sara Pai, Justin Bishop. J Clin Oncol 2014
437
40

BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC.
Paula Soares, Vítor Trovisco, Ana Sofia Rocha, Jorge Lima, Patrícia Castro, Ana Preto, Valdemar Máximo, Tiago Botelho, Raquel Seruca, Manuel Sobrinho-Simões. Oncogene 2003
505
40

FOXO3a: a novel player in thyroid carcinogenesis?
Stefan Karger, Carl Weidinger, Kerstin Krause, Sien-Yi Sheu, Thomas Aigner, Oliver Gimm, Kurt-Werner Schmid, Henning Dralle, Dagmar Fuhrer. Endocr Relat Cancer 2009
47
40


Distinct pattern of oxidative DNA damage and DNA repair in follicular thyroid tumours.
Stefan Karger, Kerstin Krause, Cornelia Engelhardt, Carl Weidinger, Oliver Gimm, Henning Dralle, Sien-Yi Sheu-Grabellus, Kurt Werner Schmid, Dagmar Fuhrer. J Mol Endocrinol 2012
22
40

NADPH oxidase DUOX1 promotes long-term persistence of oxidative stress after an exposure to irradiation.
Rabii Ameziane-El-Hassani, Monique Talbot, Maria Carolina de Souza Dos Santos, Abir Al Ghuzlan, Dana Hartl, Jean-Michel Bidart, Xavier De Deken, Françoise Miot, Ibrahima Diallo, Florent de Vathaire,[...]. Proc Natl Acad Sci U S A 2015
84
40


Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models.
T Kimura, A Van Keymeulen, J Golstein, A Fusco, J E Dumont, P P Roger. Endocr Rev 2001
360
40

Response and acquired resistance to everolimus in anaplastic thyroid cancer.
Nikhil Wagle, Brian C Grabiner, Eliezer M Van Allen, Ali Amin-Mansour, Amaro Taylor-Weiner, Mara Rosenberg, Nathanael Gray, Justine A Barletta, Yanan Guo, Scott J Swanson,[...]. N Engl J Med 2014
221
40

BRAF V600E inhibition in anaplastic thyroid cancer.
Michael H Rosove, Parvin F Peddi, John A Glaspy. N Engl J Med 2013
131
40

Integrating first-line treatment options into clinical practice: what's new in advanced melanoma?
Reinhard Dummer, Dirk Schadendorf, Paolo A Ascierto, James Larkin, Celeste Lebbé, Axel Hauschild. Melanoma Res 2015
19
40

Euthyroid goiter with and without nodules--diagnosis and treatment.
Dagmar Führer, Andreas Bockisch, Kurt Werner Schmid. Dtsch Arztebl Int 2012
20
40

RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.
Marina N Nikiforova, Roy A Lynch, Paul W Biddinger, Erik K Alexander, Gerald W Dorn, Giovanni Tallini, Todd G Kroll, Yuri E Nikiforov. J Clin Endocrinol Metab 2003
489
40

Proximity of chromosomal loci that participate in radiation-induced rearrangements in human cells.
M N Nikiforova, J R Stringer, R Blough, M Medvedovic, J A Fagin, Y E Nikiforov. Science 2000
340
40

Molecular pathogenesis of euthyroid and toxic multinodular goiter.
Knut Krohn, Dagmar Führer, Yvonne Bayer, Markus Eszlinger, Volker Brauer, Susanne Neumann, Ralf Paschke. Endocr Rev 2005
162
40

Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS.
Nishant Agrawal, Yuchen Jiao, Mark Sausen, Rebecca Leary, Chetan Bettegowda, Nicholas J Roberts, Sheetal Bhan, Allen S Ho, Zubair Khan, Justin Bishop,[...]. J Clin Endocrinol Metab 2013
148
40

Novel insights on thyroid-stimulating hormone receptor signal transduction.
Gunnar Kleinau, Susanne Neumann, Annette Grüters, Heiko Krude, Heike Biebermann. Endocr Rev 2013
78
40

Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer.
Lindsey M Kelly, Guillermo Barila, Pengyuan Liu, Viktoria N Evdokimova, Sumita Trivedi, Federica Panebianco, Manoj Gandhi, Sally E Carty, Steven P Hodak, Jianhua Luo,[...]. Proc Natl Acad Sci U S A 2014
169
40


Genomic binding and regulation of gene expression by the thyroid carcinoma-associated PAX8-PPARG fusion protein.
Yanxiao Zhang, Jingcheng Yu, Chee Lee, Bin Xu, Maureen A Sartor, Ronald J Koenig. Oncotarget 2015
13
40

TSH compensates thyroid-specific IGF-I receptor knockout and causes papillary thyroid hyperplasia.
Kathrin Müller, Dagmar Führer, Jens Mittag, Nora Klöting, Matthias Blüher, Roy E Weiss, Marie-Christine Many, Kurt Werner Schmid, Knut Krohn. Mol Endocrinol 2011
19
40

Clinical responses to vemurafenib in patients with metastatic papillary thyroid cancer harboring BRAF(V600E) mutation.
Kevin B Kim, Maria E Cabanillas, Alexander J Lazar, Michelle D Williams, Deborah L Sanders, Joseph L Ilagan, Keith Nolop, Richard J Lee, Steven I Sherman. Thyroid 2013
147
40

[Not Available].
S Ting, S T Schmid, S Synoracki, K W Schmid. Pathologe 2015
2
100


Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.
Julio C Ricarte-Filho, Mabel Ryder, Dhananjay A Chitale, Michael Rivera, Adriana Heguy, Marc Ladanyi, Manickam Janakiraman, David Solit, Jeffrey A Knauf, R Michael Tuttle,[...]. Cancer Res 2009
375
40

Association of TERT promoter mutation 1,295,228 C>T with BRAF V600E mutation, older patient age, and distant metastasis in anaplastic thyroid cancer.
Xiaoguang Shi, Rengyun Liu, Shen Qu, Guangwu Zhu, Justin Bishop, Xiaoli Liu, Hui Sun, Zhongyan Shan, Enhua Wang, Yahong Luo,[...]. J Clin Endocrinol Metab 2015
63
40

Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.
Rossella Elisei, Barbara Cosci, Cristina Romei, Valeria Bottici, Giulia Renzini, Eleonora Molinaro, Laura Agate, Agnese Vivaldi, Pinuccia Faviana, Fulvio Basolo,[...]. J Clin Endocrinol Metab 2008
328
40

Dissecting molecular events in thyroid neoplasia provides evidence for distinct evolution of follicular thyroid adenoma and carcinoma.
Kerstin Krause, Susanne Prawitt, Markus Eszlinger, Christian Ihling, Andrea Sinz, Katrin Schierle, Oliver Gimm, Henning Dralle, Frank Steinert, Sien-Yi Sheu,[...]. Am J Pathol 2011
16
40

Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing.
John W Kunstman, C Christofer Juhlin, Gerald Goh, Taylor C Brown, Adam Stenman, James M Healy, Jill C Rubinstein, Murim Choi, Nimrod Kiss, Carol Nelson-Williams,[...]. Hum Mol Genet 2015
219
40

Progress in molecular-based management of differentiated thyroid cancer.
Mingzhao Xing, Bryan R Haugen, Martin Schlumberger. Lancet 2013
365
40

Anaplastic thyroid cancers harbor novel oncogenic mutations of the ALK gene.
Avaniyapuram Kannan Murugan, Mingzhao Xing. Cancer Res 2011
144
40


MEN 2A family--prophylactic thyroidectomy for asymptomatic siblings with positive 634 codon mutation.
Sudhi Agarwal, Amit Agarwal, Gyan Chand, Sushil Kumar Gupta, Manoj Jain, Pooja Ramakant. J Assoc Physicians India 2012
2
50




Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.